KCT0008705进行中（未招募）Unknown
Diagnostic performance of SAFE score
Hanyang University Seoul Hospital0 个研究点目标入组 30,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •Among patients who performed liver fibrosis scan at the Department of Gastroenterology between 2018 and 2021, the SAFE score can be calculated
排除标准
- •1) Fibroscan
- •2) Insufficient or missing tests to determine SAFE
研究者
相似试验
尚未招募
2 期
Evaluating the safety and effectiveness of Sigol insect repellent sprayIRCT20150101020514N21Akhavi laboratory10
进行中（未招募）
不适用
Estudio de los indicadores de eficacia y seguridad de dos quelantes del hierro en pacientes con sobrecarga férrica.Tratamiento de la sobrecarga de hierroEUCTR2009-017799-26-ESInstituto Aragonés de Ciencias de la Salud
已完成
不适用
Examination about safety and the effectiveness when we switched from a GnRH antagonist to a GnRH agonist at the time of prostate cancer hormonal therapy introductioProstate CancerJPRN-UMIN000011379Kansai Medical University10
进行中（未招募）
1 期
The evaluation of the effectiveness, safety and tolerability of treatment, using a specialized prostate-specific membrane antigen (PSMA) labeled with Lutetium177, in patients with recurrent and/or metastatic adenoid cystic carcinoma originating from the salivary glands - an open, non-commercial clinical trialAdenoid cystic carcinomaCTIS2023-504699-73-00arodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy32
暂停
1 期
MINIMALLY INVASIVE PROCEDURE FOR GLAUCOMA TREATMENTCTRI/2019/08/020913Appasamy Ocular Devices Pvt Ltd